Filing Details
NEOGENOMICS INC (NASDAQ:NEO) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event.
8k filedNASDAQ:NEO
NEOGENOMICS INC (NEO) Reports Material Event to SEC
Filing Details NEOGENOMICS INC (NASDAQ:NEO) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event. Market Context NEOGENOMICS…
Market Context
NEOGENOMICS INC's stock currently trades at $14.24 with a market capitalization of $300.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for NEOGENOMICS INC's stock.
All SEC filings for NEOGENOMICS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NEO Stock Page
Frequently Asked Questions
Where can I read NEO's SEC filings?
Browse all filings on our NEO SEC filings page.
What types of SEC filings does NEOGENOMICS INC file?
Public companies like NEOGENOMICS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
